Pharmaceutical Pathway

Pipeline products for other diseases: The pipeline products targing other human disease are summarized in the table below. PPC 325 is an ant-mycobacterial compound whose structure is unlike any of the current anti-TB drugs. PPC 17 is an anti-pseudomonas compound. PM 1251 is an anti-inflammatory agent. We are currently seeking funds/partners to develop these compounds for the pharmaceutical market .

Product	Profile	Level of Development	Regulatory	Market
1 PPC 325	Tuberculosis	Animal	Indian Drug Act	India/US/Europe
2 PPC 17	Anti-infective	Animal	Indian Drug Act	India/Pacific rim
3 PM 1251	Anti-inflammatory	Animal/human clinical trails	Nutra/Bot drug	India/US/Europe